Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-25

FDA Approved: PIRFENIDONE — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original application for pirfenidone from Teva Pharmaceuticals, authorizing a generic version for idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIRFENIDONE (pirfenidone)

Snippet

ORIG AP for PIRFENIDONE (PIRFENIDONE)